Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms (Q56995802)

1

0 references

Giovanni Melandri

2

0 references

Roeland Hanemaaijer

3

0 references

Vittorio Cervi

4

0 references

Luciana Tomasi

5

0 references

Annalisa Altimari

6

0 references

Natascha Van Lent

7

0 references

Letizia Bacchi

9

0 references

Angelo Branzi

Current concepts of the pathogenesis of the acute coronary syndromes

10

0 references

language of work or name

English

0 references

publication date

March 2007

0 references

published in

Translational Research

0 references

volume

149

0 references

issue

3

0 references

page(s)

137-44

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Determination of gelatinase-A (MMP-2) activity using a novel immunocapture assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001

Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.09.001